Active surveillance in patients with a PSA >10 ng/mL

INTRODUCTION: The use of prostate-specific antigen (PSA) in active surveillance (AS) for prostate cancer is controversial. Some consider it an unreliable marker and others as sufficient evidence to exclude patients from AS. We analyzed our cohort of AS patients with a PSA over 10 ng/mL. METHODS: We...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Toren, Paul, Wong, Lih-Ming, Timilshina, Narhari, Alibhai, Shabbir, Trachtenberg, John, Fleshner, Neil, Finelli, Antonio
Médium: Artigo
Jazyk:Inglês
Vydáno: Canadian Medical Association 2014
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4216302/
https://ncbi.nlm.nih.gov/pubmed/25408810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.2121
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky